All lobbying filings

AVENUE SOLUTIONS

Lobbying for VERTEX PHARMACEUTICALS INCORPORATED · Biopharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $60,000.00 income · posted Jan 20, 2026

Official filing document

Bills named in this filing 2

HR 1227
Alternatives to PAIN Act
S 475
Alternatives to PAIN Act

Lobbying activity 2

Health Issues

Monitor issues related to 340b; Expiring healthcare extenders

Medicare/Medicaid

H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.